Mobile Health Monitoring Diagnostic Medical Device Market Report 2026

The mobile health monitoring diagnostic medical device market size has grown rapidly in recent years. It will grow from $43.65 billion in 2025 to $52.21 billion in 2026 at a compound annual growth rate (CAGR) of 19.6%. The growth in the historic period can be attributed to growth in remote diagnostics, early portable monitoring devices, expansion of wireless medical sensors, hospital telemonitoring pilots, rise in home testing devices.

The mobile health monitoring diagnostic medical device market size is expected to see rapid growth in the next few years. It will grow to $107.69 billion in 2030 at a compound annual growth rate (CAGR) of 19.8%. The growth in the forecast period can be attributed to increasing chronic disease monitoring demand, expansion of virtual care programs, higher adoption of connected diagnostics, integration with clinical analytics platforms, growth in home based diagnostics. Major trends in the forecast period include mobile connected diagnostic sensors, real time remote diagnostic monitoring, cloud linked medical devices, portable multi parameter monitors, wireless clinical monitoring systems.

The increasing adoption of remote patient monitoring solutions is anticipated to drive the growth of the mHealth monitoring diagnostic medical device market in the coming years. Remote patient monitoring (RPM) solutions refer to technologies that track patients’ health data remotely, enabling care and intervention without in-person visits. The rise in adoption of remote patient monitoring solutions is driven by improved chronic disease management, as they allow continuous monitoring of patient health and enable timely interventions without frequent in-person visits. mHealth monitoring diagnostic medical devices support remote patient monitoring by providing real-time, wearable, and connected tools that continuously collect vital signs and health data, enabling healthcare providers to track conditions, detect anomalies early, and deliver timely, personalized care remotely. For example, in January 2025, according to the Independent Health and Aged Care Pricing Authority, an Australia-based government agency, in 2022-23, virtual care (including telehealth and RPM) accounted for approximately 24% of non-admitted care in public services. Therefore, the increasing adoption of remote patient monitoring solutions is driving the growth of the mHealth monitoring diagnostic medical device market.

Companies operating in the mHealth monitoring diagnostic medical device market are focusing on developing innovative solutions, such as the first OTC glucose biosensor, to enhance accessibility to continuous health monitoring, support preventive care, and drive wider adoption of consumer-centric diagnostic technologies. The first OTC glucose biosensor is a non-prescription wearable device that continuously measures glucose levels, providing users with real-time, personalized insights to manage blood sugar and lifestyle factors without clinical supervision. For example, in August 2024, Dexcom Inc., a US-based medical device company, launched Stelo by Dexcom, the first over-the-counter continuous glucose biosensor available in the United States without a prescription, designed for adults aged 18 years and older who do not use insulin therapy. Stelo is a small, wearable sensor placed on the back of the upper arm that continuously monitors glucose levels for up to 15 days and sends the data directly to a user’s smartphone app, empowering individuals to better understand and manage their glucose patterns for improved health and wellness outcomes.

In September 2024, Veridian Healthcare LLC, a US-based manufacturer of in-home diagnostic and personal care medical products, acquired Zewa Inc. for an undisclosed amount. Through this acquisition, Veridian aims to strengthen and expand its remote patient monitoring (RPM), mHealth, and telehealth offerings by integrating Zewa’s connected and non-connected diagnostic medical devices into its portfolio. Zewa Inc. is a US-based medical device company providing digital blood pressure monitors, oximeters, thermometers, and respiratory and pain management devices.

Major companies operating in the mobile health monitoring diagnostic medical device market are Apple Inc., Garmin Ltd., ResMed Inc., Drägerwerk AG & Co. KGaA, Dexcom Inc., Masimo Corporation, Nonin Medical Inc., Biofourmis Inc., AliveCor Inc., iHealth Labs Inc., AirStrip Technologies Inc., Qardio Inc., Fora Care Inc., Sunfox Technologies, VitalConnect Inc., BioIntelliSense Inc., Sempulse Corporation, Turtle Shell Technologies Private Limited, Cardiotrack Pvt. Ltd., and Startoon Labs Private Limited.

Tariffs on medical grade sensors, wireless modules, embedded processors, and diagnostic electronics are influencing the mobile health monitoring diagnostic medical device market by raising production and integration costs. Wearable and handheld diagnostic device segments are most affected, especially where manufacturers rely on imported sensing and connectivity components from asia pacific. Higher duties can increase procurement costs for hospitals and homecare providers. However, tariffs are also driving regional manufacturing investments and supplier diversification. This supports local medical device assembly and component ecosystems.

The mobile health monitoring diagnostic medical device market research report is one of a series of new reports that provides mobile health monitoring diagnostic medical device market statistics, including mobile health monitoring diagnostic medical device industry global market size, regional shares, competitors with a mobile health monitoring diagnostic medical device market share, detailed mobile health monitoring diagnostic medical device market segments, market trends and opportunities, and any further data you may need to thrive in the mobile health monitoring diagnostic medical device industry. This mobile health monitoring diagnostic medical device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Mobile health monitoring diagnostic medical devices are technology-driven medical tools that leverage mobile health platforms, wireless connectivity, and digital sensors to monitor, detect, and evaluate patient health conditions in real time. They integrate mobile applications, cloud computing, and data analytics to enable continuous health tracking, early diagnosis, and clinical decision support. By linking patients and healthcare providers via mobile networks, these devices enhance accessibility, accuracy, and efficiency in medical diagnostics and patient care delivery.

The primary types of mobile health monitoring diagnostic medical devices include glucose monitors, blood pressure monitors, pulse oximeters, cardiac monitors, sleep apnea monitors, multi-parameter monitoring devices, and other devices. Glucose monitors are devices designed to measure blood glucose levels to manage diabetes and maintain glycemic control. These devices are available as wearable devices, handheld devices, implantable devices, mobile applications, and remote monitoring devices. They are applied across health areas including diabetes, cardiovascular diseases, central nervous system disorders, respiratory diseases, musculoskeletal conditions, smoking cessation, medication adherence, and other applications, and end users include hospitals, ambulatory surgical centers, homecare settings, diagnostic centers, and research and academic institutes.

The mobile health monitoring diagnostic medical device market consists of sales of wearable devices, portable diagnostic tools, medical sensors, mobile-enabled imaging devices, connectivity modules, gateways, and cloud-enabled health data systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.